As of May 27, 2025, THC Biomed Intl Ltd (THC.CN) reports a EV/EBITDA of -5.63.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing THC Biomed Intl Ltd's EV/EBITDA to Peers
To better understand THC Biomed Intl Ltd's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| THC Biomed Intl Ltd (THC.CN) | -5.63 |
| Grown Rogue International Inc (GRIN.CN) | 24.48 |
| Biostem Technologies Inc (BSEM) | 5.64 |
| SugarBud Craft Growers Corp (SUGR.V) | 3.31 |
| Resonate Blends Inc (KOAN) | 2.68 |
| Molecule Holdings Inc (MLCL.CN) | -0.17 |
Compared to its competitors, THC Biomed Intl Ltd's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.